Evidence map›Paper›PMID 40867291›Full record

ArticleCancers2025

Analysis of Metastases and Second Primary Malignancy Development in Patients with Invasive Transitional Cell Carcinoma of the Bladder.

Keren Rouvinov, Alexander Yakobson, Angela Tiganas, Noa Shani Shrem, Elena Chernomordikov, Ashraf Abu Jama, Nashat Abu Yasin, Ronen Brenner, Anna Ievko, Ez El Din Abu Zeid and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Keren RouvinovThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.ORCID 0000-0002-8273-4723
Alexander YakobsonThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.
Angela TiganasFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
Noa Shani ShremThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.
Elena ChernomordikovFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.ORCID 0009-0008-1017-9274
Ashraf Abu JamaThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.
Nashat Abu YasinThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.
Ronen BrennerEdith Wolfson Medical Center, Oncology Institute, Holon 58220, Israel.
Anna IevkoEdith Wolfson Medical Center, Oncology Institute, Holon 58220, Israel.
Ez El Din Abu ZeidFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
Mhammad Abu JudaFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
Walid ShalataThe Legacy Heritage Cancer Center, Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva 84105, Israel.ORCID 0000-0002-7570-4550

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bladdercancermetastasessecond primary malignanciestransitional cell carcinoma

Identifiers

PMID40867291
PMCPMC12385009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.